NCT04691128View on ClinicalTrials.gov

Desflurane and Brain Relaxation in Craniotomy

NACompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 26, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

August 31, 2021

Conditions
Supratentorial Tumor
Interventions
DRUG

Desflurane

After induction, anesthesia will be maintained with 0.8-1.3 MAC desflurane and 0.05-0.2 μg/kg/min remifentanil.

DRUG

Propofol

After induction, anesthesia will be maintained with 6-8 mg/kg/h propofol and 0.05- 0.2 μg/kg/min remifentanil

Trial Locations (1)

100070

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT04691128 - Desflurane and Brain Relaxation in Craniotomy | Biotech Hunter | Biotech Hunter